These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 15817678

  • 1. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.
    Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY.
    Blood; 2005 Aug 01; 106(3):852-9. PubMed ID: 15817678
    [Abstract] [Full Text] [Related]

  • 2. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S, Lee H, Yang Y, Jeong W.
    Free Radic Biol Med; 2013 Dec 01; 65():789-799. PubMed ID: 23954472
    [Abstract] [Full Text] [Related]

  • 3. Scoparone attenuates RANKL-induced osteoclastic differentiation through controlling reactive oxygen species production and scavenging.
    Lee SH, Jang HD.
    Exp Cell Res; 2015 Feb 15; 331(2):267-77. PubMed ID: 25576385
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
    Khapli SM, Mangashetti LS, Yogesha SD, Wani MR.
    J Immunol; 2003 Jul 01; 171(1):142-51. PubMed ID: 12816992
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor.
    Huber DM, Bendixen AC, Pathrose P, Srivastava S, Dienger KM, Shevde NK, Pike JW.
    Endocrinology; 2001 Sep 01; 142(9):3800-8. PubMed ID: 11517156
    [Abstract] [Full Text] [Related]

  • 9. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z, Jimi E, Bothwell AL.
    J Immunol; 2003 Oct 01; 171(7):3620-6. PubMed ID: 14500659
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The generation of highly enriched osteoclast-lineage cell populations.
    Quinn JM, Whitty GA, Byrne RJ, Gillespie MT, Hamilton JA.
    Bone; 2002 Jan 01; 30(1):164-70. PubMed ID: 11792580
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N, Kitaura H, Yoshida N, Nakayama K.
    Bone; 2003 Oct 01; 33(4):721-32. PubMed ID: 14555278
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation.
    Park EK, Kim MS, Lee SH, Kim KH, Park JY, Kim TH, Lee IS, Woo JT, Jung JC, Shin HI, Choi JY, Kim SY.
    Biochem Biophys Res Commun; 2004 Dec 24; 325(4):1472-80. PubMed ID: 15555594
    [Abstract] [Full Text] [Related]

  • 16. Protective Effects of Fermented Oyster Extract against RANKL-Induced Osteoclastogenesis through Scavenging ROS Generation in RAW 264.7 Cells.
    Jeong JW, Choi SH, Han MH, Kim GY, Park C, Hong SH, Lee BJ, Park EK, Kim SO, Leem SH, Jeon YJ, Choi YH.
    Int J Mol Sci; 2019 Mar 21; 20(6):. PubMed ID: 30901917
    [Abstract] [Full Text] [Related]

  • 17. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N.
    Endocrinology; 2001 Aug 21; 142(8):3656-62. PubMed ID: 11459815
    [Abstract] [Full Text] [Related]

  • 18. Rac1 GTPase regulates osteoclast differentiation through TRANCE-induced NF-kappa B activation.
    Lee NK, Choi HK, Kim DK, Lee SY.
    Mol Cell Biochem; 2006 Jan 21; 281(1-2):55-61. PubMed ID: 16328957
    [Abstract] [Full Text] [Related]

  • 19. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF.
    J Bone Miner Res; 2002 Jul 21; 17(7):1200-10. PubMed ID: 12096833
    [Abstract] [Full Text] [Related]

  • 20. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
    Sankar U, Patel K, Rosol TJ, Ostrowski MC.
    J Bone Miner Res; 2004 Aug 21; 19(8):1339-48. PubMed ID: 15231022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.